Literature DB >> 24768735

Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson's disease.

Karamkolly R Rekha1, Govindasamy P Selvakumar2.   

Abstract

Parkinson's disease (PD) is a common disabling movement disorder owing to progressive depletion of dopamine in nigrostriatal region, and can be experimentally accelerated by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). MPTP-treated mice are a representative animal model for searching for the therapeutic agents for PD without adverse effect. In this study we investigated the effect of geraniol (GE) on chronic MPTP/probenecid (MPTP/p) induced apoptotic changes in nigrostriatal region. We observed that chronic exposure to MPTP/p led to increased expression of apoptotic markers, results in neurodegeneration and motor behavioral impairments in mice. Pretreatment with GE to MPTP/p significantly improved motor functions and ameliorated striatal antioxidant balance. In addition, GE attenuated the expression of apoptotic markers evident by the normalized Bcl-2/Bax ratio and decreased expression of cytochrome-C and caspase-9 in the substantia nigra and striatum of MPTP/p induced mice model of PD. The findings of the present study suggested that GE, a new therapeutic potential avenue may have beneficial effects in slowing or preventing the progression of PD and other neurodegenerative disorders.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Geraniol; MPTP; Neuroprotective; Parkinson’s disease

Mesh:

Substances:

Year:  2014        PMID: 24768735     DOI: 10.1016/j.cbi.2014.04.010

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  6 in total

1.  Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.

Authors:  Karamkolly R Rekha; Ramu Inmozhi Sivakamasundari
Journal:  Neurochem Res       Date:  2018-08-23       Impact factor: 3.996

2.  Geraniol Pharmacokinetics, Bioavailability and Its Multiple Effects on the Liver Antioxidant and Xenobiotic-Metabolizing Enzymes.

Authors:  Barbara Pavan; Alessandro Dalpiaz; Luca Marani; Sarah Beggiato; Luca Ferraro; Donatella Canistro; Moreno Paolini; Fabio Vivarelli; Maria C Valerii; Antonietta Comparone; Luigia De Fazio; Enzo Spisni
Journal:  Front Pharmacol       Date:  2018-01-25       Impact factor: 5.810

3.  Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease.

Authors:  Jin-Xia Gao; Yu Li; Sai-Nan Wang; Xing-Chi Chen; Lu-Lu Lin; Hui Zhang
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

Review 4.  Focused Ultrasound Stimulation as a Neuromodulatory Tool for Parkinson's Disease: A Scoping Review.

Authors:  Keng Siang Lee; Benjamin Clennell; Tom G J Steward; Andriana Gialeli; Oscar Cordero-Llana; Daniel J Whitcomb
Journal:  Brain Sci       Date:  2022-02-19

5.  Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways.

Authors:  Nancy S Younis; Heba S Elsewedy; Tamer M Shehata; Maged E Mohamed
Journal:  Curr Issues Mol Biol       Date:  2021-10-24       Impact factor: 2.976

6.  Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

Authors:  Xuying Li; Pengyu Jia; Zijun Huang; Shuang Liu; Jiaxin Miao; Yuxuan Guo; Nan Wu; Dalin Jia
Journal:  Drug Des Devel Ther       Date:  2019-07-11       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.